On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
FridayNov 25, 2016 2:48 pm

NetworkNewsBreaks – Cogint, Inc. (COGT) Achieves Strong Third Quarter Revenue Growth under Guidance of Seasoned Management Team

Cogint, Inc. (NASDAQ: COGT) announced its financial results for the third quarter of 2016 earlier this month, which included a 27 percent quarter-over-quarter increase in consolidated revenue and adjusted EBITDA of $3.2 million. This performance was guided by a seasoned management team with decades of experience in multiple industries across the technology sector. Leading this team, Derek Dubner, Cogint’s chief executive officer and interim president, spent the last 15 years working closely with the late Hank Asher, the creator of market leaders Seisint and TLO who is often referred to as ‘the father of data fusion’. During this period, Dubner…

Continue Reading

TuesdayNov 22, 2016 1:44 pm

NetworkNewsBreaks – root9B (RTNB) Announces $790,000 Contract Extension for Cyber Defense

root9B, a root9B Technologies Company (OTCQB: RTNB), has extended its contract with a Fortune 500 company through October 2017 in a deal valued at more than $790,000. root9B provides advanced cyber defense operations, services and products for commercial and government clients. The company will continue to provide Manned Information Security services utilizing its ORION HUNT platform from the Adversary Pursuit Center (APC), the first-of-its-kind manned operations facility that offers real-time, remote computer network defense. root9B's cyber-defense operators remotely detect, pursue and remove advanced and dynamic cyber adversaries using the ORION platform. To view the full press release, visit: http://nnw.fm/1eBjO About…

Continue Reading

TuesdayNov 22, 2016 1:41 pm

NetworkNewsBreaks – Galenfeha, Inc. (GLFH) Divests Battery Division to Reduce Debts, advance toward Profitability

Galenfeha (OTC: GLFH) this morning reported the sale of its battery and stored energy division to Fleaux Services, LLC for a cash consideration of $350,000, as well as royalty payments on each battery sold for the next two years. Galenfeha founder and CEO James Ketner said the sale will help the company improve its balance sheet as part of aggressive efforts to curb short-term corporate obstacles.  "Galenfeha benefits from the sale by receiving cash to improve the company's balance sheet; significantly reduce SG&A costs; and move forward toward profitability… Fleaux Services can move the operation under their roof with a…

Continue Reading

TuesdayNov 22, 2016 1:39 pm

NetworkNewsBreaks – Anavex Life Sciences (AVXL) Reports Positive Data for ANAVEX 2-73 in Patients with Alzheimer’s; Shares Higher

Anavex Life Sciences (NASDAQ: AVXL) this morning issued a positive update from its phase 2a study of ANAVEX 2-73 in patients with mild-to-moderate Alzheimer’s disease. At 41 weeks, Alzheimer’s patients showed a stabilization of cognitive and functional measures taking a daily oral dosing between 10mg and 50mg of ANAVEX 2-73 in the exploratory clinical trial. The company notes the significance of this data, as current therapeutics are only able to temporarily slow the worsening of dementia symptoms rather than prevent disease progression. ANAVEX 2-73 was well tolerated, and there were no serious adverse events or clinically significant treatment-related adverse events.…

Continue Reading

FridayNov 18, 2016 12:58 pm

NetworkNewsBreaks – Apricus Biosciences, Inc. (APRI) Intends to Re-submit Vitaros NDA Following FDA Feedback; Shares Sink

Apricus Biosciences (NASDAQ: APRI) dropped 12% in mid-morning trade after announcing that it has received feedback from the FDA regarding the  previously announced Type B Meeting request to confirm Apricus’ strategy for addressing the deficiencies contained in the 2008 CRL.  The FDA’s feedback suggested additional analysis of existing clinical and non-clinical data, though it did not indicate that new clinical studies would be required for re-submission. Importantly, the FDA determined that Vitaros, under current regulations, is now considered a drug-device combination. Apricus said it believes there is “a viable regulatory pathway for resubmission of the Vitaros NDA in the U.S.”…

Continue Reading

ThursdayNov 17, 2016 1:42 pm

NetworkNewsBreaks – Arkados Group, Inc. (AKDS) to Integrate Advanced Cellular Connectivity with Airfi Networks

Arkados Group (OTC: AKDS) this morning announced its agreement to integrate Airfi Networks’ advanced cellular connectivity solutions via SIMs, connected network and machine-to-machine (M2M) communication platform, into customer devices and systems that require around the clock communication, monitoring and data gathering. Arkados is a software developer and system integrator enabling Internet of Things ("IoT") applications. Now using Airfi, once a SIM is integrated into a system, the customers’ mobile devices will be able to establish communication between the system and the customers’ chosen central application servers using Airfi’s SIM and connected networks, and transmit data on the system almost immediately.…

Continue Reading

ThursdayNov 17, 2016 1:38 pm

NetworkNewsBreaks – Immune Pharmaceuticals (IMNP): $11 Million in New Financing Supports Bertilimumab Clinical Development

Immune Pharmaceuticals (NASDAQ: IMNP) is trading higher on news that it has secured up to $11 million in new financing from an existing single family office investor. The company continues to accumulate patients in two phase 2 clinical trials for its lead candidate bertilimumab for moderate-to-severe ulcerative colitis as well as for bullous pemphigoid, an orphan autoimmune dermatological condition. The company reports that in both conditions, a significant number of patients have elevated levels of eotaxin-1, considered a biomarker of disease severity. Targeting patients with elevated eotaxin-1 offers the potential to select patients who may be more likely to respond…

Continue Reading

ThursdayNov 17, 2016 11:54 am

NetworkNewsBreaks – Plug Power, Inc. (PLUG) Signs Deal for Fuel Cell Electric Vehicle Development in China

Plug Power (NASDAQ: PLUG) is trading higher after announcing its cooperative memorandum of understanding (MOU) with Zhangjiagang Furui Special Equipment Co., LTD (Furui), along with one of the “big three” Chinese industrial vehicle manufacturers. Per the agreement, the three companies will collaborate to build electric vehicles equipped with Plug Power-designed hydrogen fueling station solutions and hybrid fuel cell engine systems. The program is expected to deliver two industrial delivery truck prototypes by March of 2017, both powered by Plug Power’s ProGen fuel cell engines. The deal also calls for a short-term project for more than 500 vehicles and a fueling…

Continue Reading

WednesdayNov 16, 2016 12:54 pm

The Female Health Company (FHCO) Names New Marketing VP for Veru Healthcare

The Female Health Company (NASDAQ: FHCO) today announced the appointment of Shiao Zhu as vice president of marketing for Veru Healthcare and the manager of the Pharmaceuticals & Medical Devices and Consumer Health divisions of The Female Health Company. Shiao Zhu has a background in both marketing and sales, including new products, branded generics, drugs for uterine fibroids, hormone replacement therapy, IUDs, infertility, human papilloma virus, and 505(b)(2) products. “In the role of Vice President of Marketing, Shiao will leverage her considerable expertise in product commercial development and positioning in men’s and women’s health and oncology to lead the marketing…

Continue Reading

WednesdayNov 16, 2016 12:51 pm

MagneGas Corp. (MNGA) Announces $3M Placement; Shares Lower

Shares of MagneGas (NASDAQ: MNGA) are down more than 16% in mid-morning trade after the waste conversion company announced its agreement with a single institutional investor for a registered direct placement of approximately $3 million.  The Securities Purchase Agreement provides for the sale of $2.5 million of pre-funded warrants which are exercisable into 5,102,041 shares and $500,000 in payment for 1,020,408 shares. The placement is expected to close on or before November 18, 2016, subject to satisfaction of customary closing conditions. To view the full press release, visit: http://nnw.fm/4lMKN About MagneGas Corporation MagneGas® Corporation (MNGA) owns a patented process that converts…

Continue Reading

Contact us: 212.418.1217